Immunity, Inflammation and Disease
© John Wiley & Sons Ltd
Each article is made available under the terms of the Creative Commons Attribution License
Editor-in-Chief Dr. Marc Veldhoen, Institute for Molecular Medicine, University of Lisbon, Portugal
Online ISSN: 2050-4527
Recently Published Issues
Meet the Editor
Marc Veldhoen, Ph.D. studied Medical Biology at the Faculty of Medicine, Utrecht University, the Netherlands. He went on to pursue his post doctorate at the National Institute for Medical Research (Mill Hill), UK, within Dr. Brigitta Stockinger’s group, where he obtained his Ph.D. in 2003. During his postdoctoral studies he stood at the basis of the description of novel T helper cell subsets; Th17 and Th9, and showed a direct link between environmental pollutants with enhanced Th17 cell responses and autoimmunity. From 2010-2016 he was a group leader at the Babraham Institute in Cambridgeshire, UK. From 2016 he moved to the Instituto de Medicina Moledular (iMM) in Lisbon, Portugal as the European Research Area chair. He continues to build upon the research he conducted previously focussing on the role of the arylhydrocarbon receptor (AhR), intraepithelial lymphocytes (IELs) and Th17 cells. His article in Cell provides insight into AhR activity that can be regulated in the intestine by dietary compounds found in leafy green vegetables. His research established a direct link between dietary phytochemicals and the maintenance of epithelial immune cells. He was awarded a prestigious 2010 ERC Starting Independent Research grant, and selected into the esteemed EMBO young investigator programme in 2011. His laboratory focus provides insights into the mechanisms that control the maintenance of resident populations of micro-organisms, and the prevention of undesirable immune responses that may result in chronic infections, allergies and autoimmunity.
Immunity, Inflammation and Disease is supported the following societies who participate in the manuscript transfer program.
Wiley Open Access has a number of social media outlets where you can get updates about Immunity, Inflammation and Disease.
Immunity, Inflammation and Disease has partnered with Publons to recognize our reviewers for their peer review contributions. Publons allows reviewers to effortlessly track, verify, and showcase their peer review activity.
Now indexed in MEDLINE
Immunity, Inflammation and Disease is delighted to announce that is it now indexed in MEDLINE®.
MEDLINE® is the National Library of Medicine® (NLM®) journal citation database. Started in the 1960s, it now provides more than 23 million references to biomedical and life sciences journal articles back to 1946.
Reasons to publish with Immunity, Inflammation and Disease:
• High standard, rigorous peer review
• Published papers indexed in PMC and MEDLINE
• Rapid publication
• Open Access – articles are published under the Creative Commons Attribution (CC-BY) license and authors are the copyright holder
• Fully compliant with open access mandates
• Wide dissemination
• Article level metrics showing statistics on readership of each paper
• Wiley’s tradition in publishing excellence
Read something you like?
You can easily share articles from IID through Facebook, Twitter, Mendeley, Reddit and more.
Start sharing research with your colleagues today. Click on the icons in the "Article Tools" menu in any article on Wiley Online Library.
Supported by Leading Journals and Societies
Immunity, Inflammation and Disease is supported by other journals published by Wiley, including a number of society-owned journals. The journals listed below support Immunity, Inflammation and Disease and participate in the Manuscript Transfer Program by referring articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Immunity, Inflammation and Disease. Immunity, Inflammation and Disease also accepts Rubriq peer review reports for qualified manuscripts.